Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Ticagrelor in Severe Community Acquired Pneumonia

ClinicalTrials.gov ID: NCT01998399

Public ClinicalTrials.gov record NCT01998399. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Trial of Ticagrelor for Severe Community Acquired Pneumonia

Study identification

NCT ID
NCT01998399
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gordon Bernard
Other
Enrollment
25 participants

Conditions and interventions

Interventions

  • Ticagrelor Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2014
Primary completion
Nov 30, 2015
Completion
Nov 30, 2015
Last update posted
Dec 10, 2017

2014 – 2015

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85724
University of Colorado Colorado Springs Colorado 80909
Denver Health Denver Colorado 80204
Atlanta VA Medical Center Atlanta Georgia 30033
Northwestern University Chicago Illinois 60611
University of Kentucky Lexington Kentucky 40536
University of Maryland Medical Center Baltimore Maryland 21201
Baystate Medical Center Springfield Massachusetts 01199
Regions Hospital Saint Paul Minnesota 55101
Moses Cone Greensboro North Carolina 27401
Cleveland Clinic Cleveland Ohio 44195
The Ohio State University Columbus Ohio 43210
Legacy Good Samaritan Medical Center Portland Oregon 97210
Legacy Emanuel Medical Center Portland Oregon 97227
Oregon Health Sciences University Portland Oregon 97239
Rhode Island Hospital Providence Rhode Island 02903
Vanderbilt University Medical Center Nashville Tennessee 37232
Baylor Houston Texas 77030
Memorial Hermann Hospital - Texas Medical Center Houston Texas 77030
South Texas Veterans Health Care System San Antonio Texas 78229
University of Texas Health Science Center San Antonio San Antonio Texas 78229
Scott & White Memorial Hospital Temple Texas 76508
Intermountain Medical Center Murray Utah 84107
University of Utah Salt Lake City Utah 84108
University of Virginia Charlottesville Virginia 22908
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01998399, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01998399 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →